Global Medtech Guidance Tracker: June 2021
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-six documents have been posted on the tracker since its last update.
You may also be interested in...
A new draft guidance from the US FDA clarifies what it considers to be remanufacturing. Companies remanufacturing devices are regulated by the agency and may require new premarket applications.
The EU’s device nomenclature is a vital key to operating the Eudamed database. A new EU document explains how it operates, who can use it and where to access the device naming scheme.
Changes to an ICH guideline could help drug companies that are being deluged with post-approval safety information to cut down on noisy, low-value data.